These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Chen YH; Lin SJ; Lin FY; Wu TC; Tsao CR; Huang PH; Liu PL; Chen YL; Chen JW Diabetes; 2007 Jun; 56(6):1559-68. PubMed ID: 17389326 [TBL] [Abstract][Full Text] [Related]
5. Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Kang L; Chen Q; Wang L; Gao L; Meng K; Chen J; Ferro A; Xu B Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e47-56. PubMed ID: 19558529 [TBL] [Abstract][Full Text] [Related]
6. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Iwakura A; Luedemann C; Shastry S; Hanley A; Kearney M; Aikawa R; Isner JM; Asahara T; Losordo DW Circulation; 2003 Dec; 108(25):3115-21. PubMed ID: 14676142 [TBL] [Abstract][Full Text] [Related]
7. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Ii M; Takenaka H; Asai J; Ibusuki K; Mizukami Y; Maruyama K; Yoon YS; Wecker A; Luedemann C; Eaton E; Silver M; Thorne T; Losordo DW Circ Res; 2006 Mar; 98(5):697-704. PubMed ID: 16484619 [TBL] [Abstract][Full Text] [Related]
8. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Verma S; Kuliszewski MA; Li SH; Szmitko PE; Zucco L; Wang CH; Badiwala MV; Mickle DA; Weisel RD; Fedak PW; Stewart DJ; Kutryk MJ Circulation; 2004 May; 109(17):2058-67. PubMed ID: 15078802 [TBL] [Abstract][Full Text] [Related]
9. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Laufs U; Werner N; Link A; Endres M; Wassmann S; Jürgens K; Miche E; Böhm M; Nickenig G Circulation; 2004 Jan; 109(2):220-6. PubMed ID: 14691039 [TBL] [Abstract][Full Text] [Related]
10. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo. Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858 [TBL] [Abstract][Full Text] [Related]
11. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079 [TBL] [Abstract][Full Text] [Related]
12. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247 [TBL] [Abstract][Full Text] [Related]
13. [Effects of clearance of superoxide anion by catechin on the expression of NO and eNOS and apoptosis in endothelial progenitor cells induced by angiotensin II]. Wu LY; Dang XQ; He XJ; Yi ZW Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):476-80. PubMed ID: 19558814 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy. Herrler T; Leicht SF; Huber S; Hermann PC; Schwarz TM; Kopp R; Heeschen C J Vasc Res; 2009; 46(4):333-46. PubMed ID: 19142013 [TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Hamed S; Brenner B; Abassi Z; Aharon A; Daoud D; Roguin A Thromb Res; 2010 Sep; 126(3):166-74. PubMed ID: 20347119 [TBL] [Abstract][Full Text] [Related]
17. High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells. Weidig P; McMaster D; Bayraktutan U Diabetes Obes Metab; 2004 Nov; 6(6):432-41. PubMed ID: 15479219 [TBL] [Abstract][Full Text] [Related]
18. Young environment reverses the declined activity of aged rat-derived endothelial progenitor cells: involvement of the phosphatidylinositol 3-kinase/Akt signaling pathway. Zhu G; Song M; Wang H; Zhao G; Yu Z; Yin Y; Zhao X; Huang L Ann Vasc Surg; 2009; 23(4):519-34. PubMed ID: 19540437 [TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin promotes endothelial progenitor cell migration and adhesion and prevents senescence. Hu Z; Zhang F; Yang Z; Zhang J; Zhang D; Yang N; Zhang Y; Cao K Cell Biol Int; 2008 Jul; 32(7):761-8. PubMed ID: 18462960 [TBL] [Abstract][Full Text] [Related]
20. Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. Zhu J; Wang X; Chen J; Sun J; Zhang F Arch Med Res; 2006 May; 37(4):484-9. PubMed ID: 16624647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]